These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31568068)

  • 61. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
    Lipska BK; Mitkus S; Caruso M; Hyde TM; Chen J; Vakkalanka R; Straub RE; Weinberger DR; Kleinman JE
    Hum Mol Genet; 2006 Sep; 15(18):2804-12. PubMed ID: 16905560
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.
    Muntjewerff JW; Gellekink H; den Heijer M; Hoogendoorn ML; Kahn RS; Sinke RJ; Blom HJ
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):99-106. PubMed ID: 17716874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis.
    Rosa A; Peralta V; Cuesta MJ; Zarzuela A; Serrano F; Martínez-Larrea A; Fañanás L
    Am J Psychiatry; 2004 Jun; 161(6):1110-2. PubMed ID: 15169701
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia.
    Park TW; Yoon KS; Kim JH; Park WY; Hirvonen A; Kang D
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):299-303. PubMed ID: 12126868
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: a population study in 543 young men.
    Stefanis NC; Van Os J; Avramopoulos D; Smyrnis N; Evdokimidis I; Hantoumi I; Stefanis CN
    Biol Psychiatry; 2004 Oct; 56(7):510-5. PubMed ID: 15450787
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity.
    Kotler M; Barak P; Cohen H; Averbuch IE; Grinshpoon A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Dec; 88(6):628-33. PubMed ID: 10581481
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain.
    Hooten WM; Hu D; Cunningham JM; Black JL
    Mol Pain; 2019; 15():1744806919848929. PubMed ID: 31041874
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Catechol-O-Methyltransferase gene (val158met) polymorphisms and anxious symptoms in early childhood: The roles of hypothalamus-pituitary-adrenal axis reactivity and life stress.
    Sheikh HI; Kryski KR; Kotelnikova Y; Hayden EP; Singh SM
    Neurosci Lett; 2017 Oct; 659():86-91. PubMed ID: 28859863
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epistatic effect of Ankyrin repeat and kinase domain containing 1 - Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population.
    Kaminskaite M; Jokubka R; Janaviciute J; Lelyte I; Sinkariova L; Pranckeviciene A; Borutaite V; Bunevicius A
    Gene; 2021 Jan; 765():145107. PubMed ID: 32889058
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The catechol-O-methyl transferase (COMT) gene and its potential association with schizophrenia: findings from a large German case-control and family-based sample.
    Nieratschker V; Frank J; Mühleisen TW; Strohmaier J; Wendland JR; Schumacher J; Treutlein J; Breuer R; Abou Jamra R; Mattheisen M; Herms S; Schmäl C; Maier W; Nöthen MM; Cichon S; Rietschel M; Schulze TG
    Schizophr Res; 2010 Sep; 122(1-3):24-30. PubMed ID: 20643532
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of Single Nucleotide Polymorphisms in Catechol-O-Methyltransferase and Serine-Threonine Protein Kinase Genes in the Pakistani Schizophrenic Population: A Study with Special Emphasis on Cannabis and Smokeless Tobacco.
    Nawaz R; Siddiqui S
    CNS Neurol Disord Drug Targets; 2015; 14(8):1086-95. PubMed ID: 25801838
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genetically based reduced MAOA and COMT functioning is associated with the cortisol stress response: a replication study.
    Bouma EM; Riese H; Doornbos B; Ormel J; Oldehinkel AJ
    Mol Psychiatry; 2012 Feb; 17(2):119-21. PubMed ID: 21912392
    [No Abstract]   [Full Text] [Related]  

  • 73. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population.
    Nunokawa A; Watanabe Y; Muratake T; Kaneko N; Koizumi M; Someya T
    Neurosci Res; 2007 Jul; 58(3):291-6. PubMed ID: 17482701
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Gene polymorphism and gene expression in schizophrenia].
    Mátyás T
    Psychiatr Hung; 2006; 21(6):404-12. PubMed ID: 17438657
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
    Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
    J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Catechol-O-methyltransferase genotype and response to Compensatory Cognitive Training in outpatients with schizophrenia.
    Burton CZ; Vella L; Kelsoe JR; Bilder RM; Twamley EW
    Psychiatr Genet; 2015 Jun; 25(3):131-4. PubMed ID: 25748092
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans.
    Lee SG; Joo Y; Kim B; Chung S; Kim HL; Lee I; Choi B; Kim C; Song K
    Hum Genet; 2005 Mar; 116(4):319-28. PubMed ID: 15645182
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.
    Lachman HM; Papolos DF; Saito T; Yu YM; Szumlanski CL; Weinshilboum RM
    Pharmacogenetics; 1996 Jun; 6(3):243-50. PubMed ID: 8807664
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Critical reappraisal of a catechol-O-methyltransferase transversion variant in schizophrenia.
    Sand PG; Domani M; Smesny S
    Biol Psychiatry; 2010 Apr; 67(7):e41-2; author reply e43-4. PubMed ID: 20060960
    [No Abstract]   [Full Text] [Related]  

  • 80. Correspondence to Sand et Al. "Critical reappraisal of a catechol-o-methyltransferase transversion variant in schizophrenia".
    Lill CM; Schjeide BM; Roehr JT; Zauft U; Allen NC; Zipp F; McQueen MB; Kavvoura FK; Ioannidis JP; Khoury MJ; Tanzi RE; Bertram L
    Biol Psychiatry; 2010 Apr; 67(7):e45-8. PubMed ID: 20303423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.